The digital health space refers to the integration of technology and health care services to improve the overall quality of health care delivery. It encompasses a wide range of innovative and emerging technologies such as wearables, telehealth, artificial intelligence, mobile health, and electronic health records (EHRs). The digital health space offers numerous benefits such as improved patient outcomes, increased access to health care, reduced costs, and improved communication and collaboration between patients and health care providers. For example, patients can now monitor their vital signs such as blood pressure and glucose levels from home using wearable devices and share the data with their doctors in real-time. Telehealth technology allows patients to consult with their health care providers remotely without having to travel to the hospital, making health care more accessible, particularly in remote or rural areas. Artificial intelligence can be used to analyze vast amounts of patient data to identify patterns, predict outcomes, and provide personalized treatment recommendations. Overall, the digital health space is rapidly evolving, and the integration of technology in health

Monday, December 4, 2023

Guidance for Industry and Food and Drug Administration Staff

Despite the enormous flurry of bad press about the FDA and CDC these agencies are constantly improivng their resistance to attacks on their networks.  The FDA has an extensive department dedicated to one thing...guarding device security for mobile devices.  Each application for mobile devices and remote monitoring must be cybersecure and assessed for resistance to unauthorized intrusion.

This document provides FDA’s recommendations to industry regarding cybersecurity device design, labeling, and the documentation that FDA recommends be included in premarket submissions for devices with cybersecurity risk. These recommendations are intended to promote consistency, facilitate efficient premarket review, and help ensure that marketed medical devices are sufficiently resilient to cybersecurity threats. This document supersedes the final guidance “Content of Premarket Submissions for Management of Cybersecurity in Medical Devices,” issued October 2, 2014.

Rest easy, your medications may not be safe, or effective, but the FDA is secure.

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)